Demand for Transdermal Skin Patches in UK

Demand for Transdermal Skin Patches in UK Size and Share Forecast Outlook 2025 to 2035

Demand for transdermal skin patches in UK is projected to grow from USD 461.0 million in 2025 to USD 719.8 million by 2035, at a CAGR of 4.6%. Multi-Layer Drug-in-Adhesive will dominate with a 38.5% market share, while pain relief will lead the application segment with a 42.8% share.

Demand for Transdermal Skin Patches in UK
  • FACT12607MR
  • 15 Dec 2025
  • Healthcare
  • 170 Pages
  • 6 Tables
  • 21 Figures

Table of Content

  1. Executive Summary
    • UK Market Outlook
    • Demand to side Trends
    • Supply to side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. UK Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
    • Historical Market Size Value (USD Million) Analysis, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
      • Y to o to Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. UK Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
  6. UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Type
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Type, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Type, 2025 to 2035
      • Multi-Layer Drug-in-Adhesive
      • Matrix
      • Reservoir
      • Vapor Patches
    • Y to o to Y Growth Trend Analysis By Type, 2020 to 2024
    • Absolute $ Opportunity Analysis By Type, 2025 to 2035
  7. UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Application
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Application, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2025 to 2035
      • Pain Relief
      • Cardiovascular
      • Hormone Replacement
      • Central Nervous System Disorders
    • Y to o to Y Growth Trend Analysis By Application, 2020 to 2024
    • Absolute $ Opportunity Analysis By Application, 2025 to 2035
  8. UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2024
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
      • UK
    • Market Attractiveness Analysis By Region
  9. UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
      • By Type
      • By Application
    • Market Attractiveness Analysis
      • By Country
      • By Type
      • By Application
    • Key Takeaways
  10. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Type
      • By Application
  11. Competition Analysis
    • Competition Deep Dive
      • Teva Pharmaceutical Industries Limited
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Novartis AG
      • Johnson & Johnson
      • Teikoku Pharma UK Incorporated
      • Viatris Incorporated
      • Luye Pharma Group Limited
      • GlaxoSmithKline plc
      • AstraZeneca plc
      • Pfizer Incorporated
      • Boehringer Ingelheim International GmbH
  12. Assumptions & Acronyms Used
  13. Research Methodology

List Of Table

  • Table 1: UK Market Value (USD Million) Forecast by Region, 2020 to 2035
  • Table 2: UK Market Value (USD Million) Forecast by Type, 2020 to 2035
  • Table 3: UK Market Value (USD Million) Forecast by Application, 2020 to 2035
  • Table 4: UK Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 5: UK Market Value (USD Million) Forecast by Type, 2020 to 2035
  • Table 6: UK Market Value (USD Million) Forecast by Application, 2020 to 2035

List Of Figures

  • Figure 1: UK Market Pricing Analysis
  • Figure 2: UK Market Value (USD Million) Forecast 2020 to 2035
  • Figure 3: UK Market Value Share and BPS Analysis by Type, 2025 and 2035
  • Figure 4: UK Market Y to o to Y Growth Comparison by Type, 2025 to 2035
  • Figure 5: UK Market Attractiveness Analysis by Type
  • Figure 6: UK Market Value Share and BPS Analysis by Application, 2025 and 2035
  • Figure 7: UK Market Y to o to Y Growth Comparison by Application, 2025 to 2035
  • Figure 8: UK Market Attractiveness Analysis by Application
  • Figure 9: UK Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
  • Figure 10: UK Market Y to o to Y Growth Comparison by Region, 2025 to 2035
  • Figure 11: UK Market Attractiveness Analysis by Region
  • Figure 12: UK Market Incremental Dollar Opportunity, 2025 to 2035
  • Figure 13: UK Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 14: UK Market Value Share and BPS Analysis by Type, 2025 and 2035
  • Figure 15: UK Market Y to o to Y Growth Comparison by Type, 2025 to 2035
  • Figure 16: UK Market Attractiveness Analysis by Type
  • Figure 17: UK Market Value Share and BPS Analysis by Application, 2025 and 2035
  • Figure 18: UK Market Y to o to Y Growth Comparison by Application, 2025 to 2035
  • Figure 19: UK Market Attractiveness Analysis by Application
  • Figure 20: UK Market - Tier Structure Analysis
  • Figure 21: UK Market - Company Share Analysis

Demand for Transdermal Skin Patches in UK